Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-rich plasma versus betamethasone for rotator cuff impingement syndrome
RBR-5bt6kdPhase 3Completed
- Sponsor
- Universidade Tiradentes
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma and betamethasone dipropionate in rotator cuff tendinitis and shoulder tendinitis (2 arms), sponsored by Universidade Tiradentes. Primary endpoint: Not reported. Started May 2016; status: completed.
02
Drugs
platelet-rich plasmabetamethasone dipropionate
03
Conditions
rotator cuff tendinitisshoulder tendinitis
Beyond the preview
Go deeper on RBR-5bt6kd.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5bt6kd.